نتایج جستجو برای: autoimmune bullous disease

تعداد نتایج: 1532097  

Journal: :Therapeutics and Clinical Risk Management 2007

2013
Stefan Tukaj Konrad Kleszczyński Katerina Vafia Stephanie Groth Damian Meyersburg Piotr Trzonkowski Ralf J. Ludwig Detlef Zillikens Enno Schmidt Tobias W. Fischer Michael Kasperkiewicz

The cell stress chaperone heat shock protein 90 (Hsp90) has been implicated in inflammatory responses and its inhibition has proven successful in different mouse models of autoimmune diseases, including epidermolysis bullosa acquisita. Here, we investigated expression levels and secretory responses of Hsp90 in patients with bullous pemphigoid (BP), the most common subepidermal autoimmune bliste...

Journal: :Journal of Investigative Dermatology 2008

2009
E. Telegdy

E. Telegdy, I. Schneider, Department of Dermatology, University Medical School, Pécs (Hungary) Sir, The association of cutaneous T cell malignant lymphoma (CTCL) and a vesiculobullous disease is extremely rare. Kaposi [1] in 1887 presented the first report of a pemphigus-like dermal lesion associated with mycosis fungoides. Since then a few associations of CTCL and other autoimmune bullous dise...

Journal: :Archives of dermatology 2009
Jennifer M Gardner Katherine G Evans Steven Goldstein Ellen J Kim Carmela C Vittorio Alain H Rook

Histone deacetylase (HDAC) inhibitors represent a novel class of medication that is being targeted for use in the treatment of cancer. A member of this class, vorinostat, has recently been approved for the therapy of cutaneous T-cell lymphoma. Importantly, emerging data from animal studies have indicated that HDAC inhibitors may have the capacity to potently suppress the development of autoimmu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید